Evidence-based Chinese medicine for cancer therapy

Journal of Ethnopharmacology

Volumn 116, Issue 2, 2008, Pages 207-210

  Konkimalla, V Badireenath ^a   Efferth, Thomas ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Cancer therapy; Clinical trial; Meta analysis; Molecular pharmacology; Pharmacognosy; Traditional Chinese medicine

Indexed keywords

ARSENIC TRIOXIDE; ASTRAGALUS EXTRACT; CAMPTOTHECIN; EMODIN; EPIGALLOCATECHIN; GARLIC EXTRACT; GINSENG EXTRACT; HOMOHARRINGTONINE; HYPERICUM PERFORATUM EXTRACT; IMATINIB; IRINOTECAN; LIPOXYGENASE; PLANT EXTRACT; PROTEIN KINASE C;

ACUPUNCTURE; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RESEARCH; CANCER THERAPY; CHINA; CHINESE MEDICINE; CLINICAL STUDY; DISEASE COURSE; DRUG BINDING; DRUG EFFICACY; DRUG INHIBITION; DRUG MECHANISM; DRUG QUALITY; DRUG SAFETY; DRUG STRUCTURE; DRUG SYNTHESIS; EVIDENCE BASED MEDICINE; HERBAL MEDICINE; HUMAN; MOXIBUSTION; QUALITY CONTROL; TREATMENT RESPONSE;

EID: 39149109582     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2007.12.009     Document Type: Note

References (15)

1. Battistutta R., Sarno S., De Moliner E., Papinutto E., Zanotti G., and Pinna L.A. The replacement of ATP by the competitive inhibitor emodin induces conformational modifications in the catalytic site of protein kinase CK2. Journal of Biological Chemistry 275 (2000) 29618-29622
2. Efferth T.W. Schwabe Award 2006: antiplasmodial and antitumor activity of artemisinin-from bench to bedside. Planta Medica 73 (2007) 299-309
3. Efferth T., Fu Y.J., Zu Y.G., Schwarz G., Konkimalla V.S., and Wink M. Molecular target-guided tumor therapy with natural products derived from traditional Chinese medicine. Current Medicinal Chemistry 14 (2007) 2024-2032
4. Efferth T., Li P.C., Konkimalla V.S., and Kaina B. From traditional Chinese medicine to rational cancer therapy. Trends in Molecular Medicine 13 (2007) 353-361
5. Efferth T., Miyachi H., and Bartsch H. Pharmacogenomics of a traditional Japanese herbal medicine (Kampo) for cancer therapy. Cancer Genomics and Proteomics 4 (2007) 81-91
6. Ezzo J., Vickers A., Richardson M.A., et al. Acupuncture-point stimulation for chemotherapy-induced nausea and vomiting. Journal of Clinical Oncology 23 (2005) 7188-7198
7. McCulloch M., See C., Shu X.J., et al. Astragalus-based Chinese herbs and platinum-based chemotherapy for advanced non-small-cell lung cancer: meta-analysis of randomized trials. Journal of Clinical Oncology 24 (2006) 419-430
8. Mills E., Wu P., Johnston B.C., Gallicano K., Clarke M., and Guyatt G. Natural health product-drug interactions: a systematic review of clinical trials. Therapeutic Drug Monitoring 27 (2005) 549-557
9. Newman D.J., and Cragg G.M. Natural products as sources of new drugs over the last 25 years. Journal of Natural Products 70 (2007) 461-477
10. Nortier J.L., Martinez M.C., Schmeiser H.H., et al. Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi). The New England Journal of Medicine 342 (2000) 1686-1692
11. Pan C.X., Morrison R.S., Ness J., Fugh-Berman A., and Leipzig R.M. Complementary and alternative medicine in the management of pain, dyspnea, and nausea and vomiting near the end of life. A systematic review. Journal of Pain and Symptom Management 20 (2000) 374-387
12. Shu X., McCulloch M., Xiao H., Broffman M., and Gao J. Chinese herbal medicine and chemotherapy in the treatment of hepatocellular carcinoma: a meta-analysis of randomized controlled trials. Integrative Cancer Therapy 4 (2005) 219-229
13. Singh Y.N. Potential for interaction of kava and St. John's wort with drugs. Journal of Ethnopharmacology 100 (2005) 108-113
14. Skrzypczak-Jankun E., Zhou K., and Jankun J. Inhibition of lipoxygenase by (-)-epigallocatechin gallate: X-ray analysis at 2,1 A reveals degradation of EGCG and shows soybean LOX-3 complex with EGC instead. International Journal of Molecular Medicine 12 (2003) 415-420
15. Stermitz F.R., Lorenz P., Tawara J.N., Zenewicz L.A., and Lewis K. Synergy in a medicinal plant: antimicrobial action of berberine potentiated by 5′-methoxyhydnocarpin, a multidrug pump inhibitor. Proceedings of the National Academy of Science USA 97 (2000) 1433-1437